Chung H S

Hosking S L, Harris A, Chung H S, Jonescu-Cuypers C P, Kagemann L, Roff Hilton E J et al.

This study found glaucoma patients exhibit relative ocular vasoconstriction, partially reversed by increased CO2. This suggests compromised blood flow regulation in glaucoma.

Harris A, Ishii Y, Chung H S, Jonescu-Cuypers C P, McCranor L J, Kagemann L et al.

This study found the inferior retina has lower blood flow per nerve tissue volume, suggesting it's more vulnerable to glaucoma damage from elevated IOP or ischemia.

Harris A, Arend O, Chung H S, Kagemann L, Cantor L, Martin B

In normal-tension glaucoma, dorzolamide, unlike betaxolol, improved inferotemporal retinal blood flow despite both lowering IOP. This suggests dorzolamide may offer additional neuroprotection beyond pressure reduction.

Harris A, Chung H S, Ciulla T A, Kagemann L

New technologies for measuring ocular blood flow reveal deficits in glaucoma and AMD, highlighting OBF's critical role in understanding and potentially managing these blinding diseases.

Evans D W, Harris A, Garrett M, Chung H S, Kagemann L

Glaucoma patients exhibit impaired central retinal artery blood flow regulation during posture changes, unlike healthy individuals. This suggests faulty ocular autoregulation may contribute to glaucoma pathology.

Ren J, Shin D H, Chung H S, Birt C M, Glover B K, Juzych M S et al.

This study found pilocarpine 4% is more effective than apraclonidine 1% for preventing post-laser IOP spikes, especially beneficial for patients already on apraclonidine.

Harris A, Garzozi H J, Chung H S

Chung H S, Harris A, Evans D W, Kagemann L, Garzozi H J, Martin B

Glaucoma involves vascular deficits, potentially linked to IOP and impaired autoregulation, impacting optic nerve health. Improving ocular blood flow may offer a therapeutic strategy.

Chung H S, Harris A, Kagemann L, Martin B

This study found normal tension glaucoma patients have significantly reduced peripapillary retinal blood flow, suggesting vascular deficits contribute to disease development and progression.

Evans D W, Harris A, Chung H S, Cantor L B, Garzozi H J

Long-term beta-blocker therapy for POAG significantly improved altered retrobulbar blood flow (CRA/SPCA resistance), suggesting a positive impact on ocular hemodynamics beyond just IOP reduction.

Birt C M, Shin D H, McCarty B, Kim C, Lee D T, Chung H S

This study compared Ophthimus (high-pass resolution) and Humphrey perimetry in glaucoma. Ophthimus was faster with better reliability, but its unique "neural capacity" offered no clear clinical advantage over standard Humphrey measures.

Kagemann L, Harris A, Chung H S, Evans D, Buck S, Martin B

HRF blood flow measurements are stable despite laser angle but vary with camera distance. Best reproducibility for clinical use comes from whole-image pixel-by-pixel analysis.

Chung H S, Shin D H, Birt C M, Kim C, Lee D, Levin D S et al.

Chronic apraclonidine use reduces the effectiveness of prophylactic apraclonidine 1.0% in preventing post-laser IOP spikes. Clinically, monitor these patients closely and prepare alternative treatments for IOP spikes.